Trial Site Detail

 

Drug:
IPI-504
Trial:
Study of IPI-504 in GIST patients following failure of at least imatinib and sunitinib
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Terminated

 

Universitatsklinikum Essen, West Germany Cancer Center

Hufelandstr. 55     
Essen , 45122
Germany

 

Principal Investigator:
Sebastian Bauer, MD
Contact:
Edel O' Halloran +49 (0) 201 723 3147 sebastian.bauer@uni-due.de edel.ohalloran@uk-essen.de
Activation Status of this Site:
Closed
Notes about this Site:
Universitatsklinikum Essen, West Germany Cancer Center Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.